Pair Name | Oleanolic Acid, Gemcitabine | ||
Phytochemical Name | Oleanolic Acid (PubChem CID: 10494 ) | ||
Anticancer drug Name | Gemcitabine (PubChem CID: 60750 ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Pair Name | Oleanolic Acid, Gemcitabine | |||
Disease Info | [ICD-11: 2C10] | Pancreatic cancer | Investigative | |
Biological Phenomena | Induction-->Mitochondrial damage | |||
Gene Regulation | Down-regulation | Expression | EGFR | hsa1956 |
Down-regulation | Expression | EZH2 | hsa2146 | |
Down-regulation | Expression | MAP2K7 | hsa5609 | |
Down-regulation | Expression | MAPK1 | hsa5594 | |
Down-regulation | Expression | SPINK1 | hsa6690 | |
In Vitro Model | AsPC-1 | Pancreatic ductal adenocarcinoma | Homo sapiens (Human) | CVCL_0152 |
MIA PaCa-2 | Pancreatic ductal adenocarcinoma | Homo sapiens (Human) | CVCL_0428 | |
Result | We found an interesting finding that the 73-03 in combination with GCB can improve GCB efficacy and decrease PCa resistance, which induced apoptosis and mitochondrial damage through epigenetic inhibition of SPINK1 transcription by miR-421 up-regulation. This was the first study that used OA derivatives on GCB-resistant PCa cells, so this combined strategy warrants further investigation. |
No. | Title | Href |
---|---|---|
1 | Enhancement of gemcitabine efficacy by K73-03 via epigenetically regulation of miR-421/SPINK1 in gemcitabine resistant pancreatic cancer cells. Phytomedicine. 2021 Oct;91:153711. doi: 10.1016/j.phymed.2021.153711. | Click |